增强子塌陷导致PKHD1沉默及中心体介导的染色体不稳定性与转移在透明细胞肾细胞癌中的作用
Enhancer Collapse Dictates PKHD1 Silencing and Centrosome-Mediated Chromosomal Instability and Metastasis in Clear Cell Renal Cell Carcinoma
Yueyang Wang, Lingling Wang, Jingwen Deng, Zhou Tian, Zhiyong Liang, Honghe Zhang
Journal:EXPERIMENTAL CELL RESEARCH
IF:3.5
DOI:10.1016/j.yexcr.2026.115150
PMID:42586231
Published:2026-08-12
research field:肿瘤学分子生物学生物化学
Abstract
Integration of single-cell and spatial transcriptomics identifies PKHD1 loss as a pivotal biomarker for cellular dedifferentiation and poor prognosis. • Identification of the PKHD1-CEP97-CP110 axis as a novel guardian of centrosome homeostasis and genomic integrity in ccRCC. • Discovery of a distal 800-kb enhancer as the primary driver for PKHD1 silencing via 3D chromatin looping disruption. Chromosomal instability (CIN) drives clear cell renal cell carcinoma (ccRCC) progression, yet its upstream triggers remain elusive. To identify key drivers governing renal genomic integrity, we integrated machine learning-driven screening with Mendelian randomization analysis to prioritize candidates associated with both CIN and clinical outcomes. This computational pipeline identified Polycystic Kidney and Hepatic Disease 1 ( PKHD1 ) as a top candidate and a crucial guardian of the renal genome. Through single-cell and spatial transcriptomics, combined with functional assays in ccRCC cell lines and clinical cohort validation, we characterized the expression dynamics and biological function of PKHD1 . Mechanistically, PKHD1 localizes to the centrosome, where it maintains the CEP97-CP110 complex. Depletion of PKHD1 leads to the loss of CP110 at the centrosome, thereby triggering both CIN and epithelial-to-mesenchymal transition (EMT). We further demonstrate that PKHD1 is silenced in ccRCC through the epigenetic inactivation of a distal 800-kb enhancer, which physically interacts with the PKHD1 gene within a shared topologically associating domain (TAD). Collectively, this study establishes a novel link between 3D genomic regulation and centrosome homeostasis, identifying the loss of the PKHD1-CEP97-CP110 axis as a pivotal event in kidney cancer progression and a potential biomarker for aggressive disease.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


